Dr. Daniel Cameron

UPDATED: April 8, 2021 Could monoclonal antibodies prevent lyme disease? The first human clinical trial of Lyme PrEP, a seasonal shot to prevent Lyme disease, has begun enrolling volunteers to evaluate the safety and pharmacology of the treatment. [1] “Lyme PrEP prevents infection by delivering a single, human anti-Lyme antibody, or blood protein, directly to […]

Investigators reviewed questionnaires from 778 Lyme disease patients treated at the Geisinger Clinic, a health system in Pennsylvania. The authors determined the length of time a patient was ill before seeking medical attention, and the length of time between seeking care for Lyme disease and receiving lyme treatment. They found that the amount of time

PERSPECTIVE A growing number of specialties have described a shift to utilizing telemedicine in their practices. “The global pandemic of COVID-19 has dramatically altered the delivery of rheumatology outpatient services because of the redeployment of staff and efforts to minimize infection risk to patients and clinicians in line with physical distancing guidance,” writes Yeoh and colleagues. “Departments

I have identified several factors that might have contributed to treatment delays in 15 Lyme disease patients. All 15 subjects failed their initial antibiotic treatment. In many cases, their illness could have been mitigated had diagnosis and treatment occurred in the early stages of the disease. These 15 patients were part of a case series